Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$739M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Deere & Co
DE
|
+$530M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
| 5 |
Cboe Global Markets
CBOE
|
+$413M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$955M |
| 2 |
UnitedHealth
UNH
|
+$745M |
| 3 |
XYZ
Block Inc
XYZ
|
+$545M |
| 4 |
Amazon
AMZN
|
+$536M |
| 5 |
PPG Industries
PPG
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.89% |
| 2 | Financials | 21.6% |
| 3 | Industrials | 15.25% |
| 4 | Technology | 11.5% |
| 5 | Communication Services | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rallybio
RLYB
$89.4M
| $10M | 0.04% |
524,347
| – | – |
|
77
Trevi Therapeutics
TRVI
$2.56B
| $5.9M | 0.02% |
4,400,000
| – | – |
|
|
KNTE
78
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $4.31M | 0.02% |
1,820,462
| – | – |
|
79
Arthur J. Gallagher & Co
AJG
$67.6B
| – | – |
-957,820
| Closed | -$218M |
|
80
Arm
ARM
$260B
| – | – |
-600,000
| Closed | -$32.1M |
|
81
Maplebear
CART
$11.5B
| – | – |
-125,000
| Closed | -$3.71M |
|
|
CFLT
82
DELISTED
Confluent
CFLT
| – | – |
-1,983,066
| Closed | -$58.7M |
|
83
Colgate-Palmolive
CL
$72.6B
| – | – |
-1,424,845
| Closed | -$101M |
|
84
Datadog
DDOG
$84.6B
| – | – |
-668,511
| Closed | -$60.9M |
|
85
Dollar General
DG
$27.2B
| – | – |
-368,172
| Closed | -$39M |
|
86
Dover
DOV
$27.2B
| – | – |
-536,587
| Closed | -$74.9M |
|
87
Fortinet
FTNT
$113B
| – | – |
-7,050,550
| Closed | -$414M |
|
88
lululemon athletica
LULU
$13.7B
| – | – |
-776,515
| Closed | -$299M |
|
89
Mobileye
MBLY
$7.68B
| – | – |
-1,011,692
| Closed | -$42M |
|
|
90
Microsoft
MSFT
$3.59T
| – | – |
-3,024,399
| Closed | -$955M |
|
91
Synopsys
SNPS
$76.2B
| – | – |
-308,059
| Closed | -$141M |
|
92
Tenet Healthcare
THC
$22.6B
| – | – |
-1,025,840
| Closed | -$67.6M |
|
93
Unum
UNM
$13.9B
| – | – |
-4,778,110
| Closed | -$235M |
|
|
GTM
94
ZoomInfo Technologies
GTM
$1.16B
| – | – |
-3,754,192
| Closed | -$61.6M |
|
|
XYZ
95
Block Inc
XYZ
$49.4B
| – | – |
-12,324,808
| Closed | -$545M |
|
|
KRTX
96
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-1,131,263
| Closed | -$191M |
|
|
FTCH
97
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| – | – |
-10,844,009
| Closed | -$22.7M |
|
Similar funds
Andreas Halvorsen's Q4 2023 Portfolio in Review
As of Q4 2023, Andreas Halvorsen held 98 positions worth $27.3B, up 11% from $24.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Andreas Halvorsen's Q4 2023 filing shows 18 new, 23 increased, 21 reduced and 19 closed positions. Its largest new stake was Advanced Micro Devices: 4,737,399 shares worth $698M. The largest sale was Microsoft, an estimated $955M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Andreas Halvorsen's largest Q4 2023 buy was Advanced Micro Devices: 4,737,399 shares worth $698M.
- Andreas Halvorsen added most to Progressive in Q4 2023, an estimated $739M increase.
- Andreas Halvorsen's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $745M.
- Andreas Halvorsen fully exited Microsoft in Q4 2023, selling an estimated $955M.
- Andreas Halvorsen's ten largest holdings make up 40% of its $27.3B portfolio in Q4 2023.
- Andreas Halvorsen opened 18 new positions and closed 19 in Q4 2023.
- Andreas Halvorsen's portfolio value rose 11% quarter-over-quarter to $27.3B.
Based on Viking Global Investors's 13F filing for Q4 2023, filed 14 Feb 2024.